Report: Medtronic helped draft, edit medical journal articles
A US Senate Finance Committee report alleges that Medtronic was heavily involved in drafting, editing and shaping the content of medical journal articles authored by its physician consultants involving its InFuse bone growth product used in spine surgery. This information was not disclosed, raising serious questions about the research conducted. Medtronic was paid $210 million over several years through royalties and consulting fees.
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- Business Roundup: M&A Activity Down Slightly in First Half of 2014
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- Large Employers Trimming Healthcare Spending
- CNO on Hospital Redesign: 'You Can't Over-Communicate'